Page 28 - Ognitive Function News Today

There’s no shortage of influencers out there and we’ve witnessed a good share of trends come and go. With many of those posts by amateurs, we decided to talk with someone who's got her boots on the ground of the nutraceutical ingredient industry.

Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people.

Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic, and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

The UK Food Standards Agency (FSA) has today issued new precautionary advice on CBD, recommending healthy adults should limit their consumption of CBD from food to 10mg per day.

The supplementation of curcumin encapsulated within fenugreek mucilage has shown to improve cognitive and locomotive function of patients suffering from mild dementia, according to a six-month-long RCT conducted in India.

After two very good years of growth, sales of children’s supplement have declined over the past 12 months, but another wave of growth could be just around the corner.

Early detection of micronutrient deficiencies could significantly improve the clinical prognosis for patients with neurodegenerative diseases, using therapeutic intervention to replenish or enhance plasma levels, according to researchers.

Understanding the impact of sitting on cognitive health is the first step in combatting this phenomenon. TheHealthSite.com

Norwegian fish and microalgae oil supplier GC Rieber VivoMega is partnering with nutritional analytics firm OmegaQuant to provide free Omega-3 Index testing at the SupplySide West trade show in Las Vegas on Oct. 25-26.